Incomplete Stent Apposition and Delayed Tissue Coverage Are More Frequent in Drug-Eluting Stents Implanted During Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Than in Drug-Eluting Stents Implanted for Stable/Unstable Angina. Insights From Optical Coherence Tomography

JACC: Cardiovascular Interventions

Volumn 2, Issue 5, 2009, Pages 445-452

  Gonzalo, Nieves ^a   Barlis, Peter ^a   Serruys, Patrick W ^a   Garcia Garcia, Hector M ^a   Onuma, Yoshinobu ^a   Ligthart, Jurgen ^a   Regar, Evelyn ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

drug eluting stents; optical coherence tomography; ST segment elevation myocardial infarction; stent apposition; stent coverage

Indexed keywords

BIOLIMUS; EVEROLIMUS; PACLITAXEL; RAPAMYCIN; RAPAMYCIN DERIVATIVE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; HEART INFARCTION; HUMAN; IMPLANTATION; IN-STENT RESTENOSIS; MALE; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS; ANALOGS AND DERIVATIVES; ANGINA PECTORIS; ANGINA, UNSTABLE; COMPARATIVE STUDY; CORONARY RESTENOSIS; DRUG EFFECTS; MIDDLE AGED; MYOCARDIAL INFARCTION; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; PROSPECTIVE STUDY; RISK FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY; VASCULAR ENDOTHELIUM;

ANGINA PECTORIS; ANGINA, UNSTABLE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PACLITAXEL; PROSPECTIVE STUDIES; RISK FACTORS; SIROLIMUS; TOMOGRAPHY, OPTICAL COHERENCE; ANGIOPLASTY, BALLOON, CORONARY;

EID: 65549170720     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2009.01.012     Document Type: Article

References (26)

1. Boden W.E., Eagle K., and Granger C.B. Reperfusion strategies in acute ST-segment elevation myocardial infarction: a comprehensive review of contemporary management options. J Am Coll Cardiol 50 (2007) 917-929
2. Urban P., Gershlick A.H., Guagliumi G., et al. Safety of coronary sirolimus-eluting stents in daily clinical practice: 1-year follow-up of the e-Cypher registry. Circulation 113 (2006) 1434-1441
3. Alfonso F., Suarez A., Perez-Vizcayno M.J., et al. Intravascular ultrasound findings during episodes of drug-eluting stent thrombosis. J Am Coll Cardiol 50 (2007) 2095-2097
4. Cook S., Wenaweser P., Togni M., et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation 115 (2007) 2426-2434
5. Joner M., Finn A.V., Farb A., et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48 (2006) 193-202
6. Spaulding C., Henry P., Teiger E., et al. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 355 (2006) 1093-1104
7. Daemen J., Tanimoto S., Garcia-Garcia H.M., et al. Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction. (from the RESEARCH and T-SEARCH Registries). Am J Cardiol 99 (2007) 1027-1032
8. Hong M.K., Mintz G.S., Lee C.W., et al. Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation 113 (2006) 414-419
9. Bouma B.E., Tearney G.J., Yabushita H., et al. Evaluation of intracoronary stenting by intravascular optical coherence tomography. Heart 89 (2003) 317-320
10. Kubo T., Imanishi T., Kitabata H., et al. Comparison of vascular response after sirolimus eluting stent implantation between patients with unstable and stable angina pectoris. A serial optical coherence tomography study. J Am Coll Cardiol Img 1 (2008) 475-484
11. Finn A.V., Nakazawa G., Ladich E., Kolodgie F.D., and Virmani R. Does underlying plaque morphology play a role in vessel healing after drug eluting stent implantation?. J Am Coll Cardiol Img 1 (2008) 485-488
12. Degertekin M., Serruys P.W., Tanabe K., et al. Long-term follow-up of incomplete stent apposition in patients who received sirolimus-eluting stent for de novo coronary lesions: an intravascular ultrasound analysis. Circulation 108 (2003) 2747-2750
13. Tanabe K., Serruys P.W., Degertekin M., et al. Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial. Circulation 111 (2005) 900-905
14. Xie Y., Takano M., Murakami D., et al. Comparison of neointimal coverage by optical coherence tomography of a sirolimus-eluting stent versus a bare-metal stent three months after implantation. Am J Cardiol 102 (2008) 27-31
15. Schinkel A.F.L., van Beusekom H.M.M., Maugenest A.M., van Wunnik S., Serruys P.W., and Regar E. OCT Findings in very late (4 years) paclitaxel-eluting stent thrombosis. J Am Coll Cardiol Intv 1 (2008) 449-451
16. Barlis P., DiMario C., van Beusekom H.M.M., Gonzalo N., and Regar E. Novelties in cardiac imaging-optical coherence tomography (OCT). A critical appraisal of the safety concerns tempering the success of drug-eluting stents Eurointervention 4 Suppl C (2008) C22-C26
17. Serruys P.W., Degertekin M., Tanabe K., et al. Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial. Circulation 106 (2002) 798-803
18. Prati F., Zimarino M., Stabile E., et al. Does optical coherence tomography identify arterial healing after stenting?. An in vivo comparison with histology, in a rabbit carotid model. Heart 94 (2008) 217-221
19. Matsumoto D., Shite J., Shinke T., et al. Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography. Eur Heart J 28 (2007) 961-967
20. Takano M., Yamamoto M., Inami S., et al. Long-term follow-up evaluation after sirolimus-eluting stent implantation by optical coherence tomography: do uncovered struts persist?. J Am Coll Cardiol 51 (2008) 968-969
21. Nakazawa G., Finn A.V., Joner M., et al. Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study. Circulation 118 (2008) 1138-1145
22. Virmani R., Burke A.P., Farb A., and Kolodgie F.D. Pathology of the vulnerable plaque. J Am Coll Cardiol 47 (2006) C13-C18
23. Hwang C.W., Levin A.D., Jonas M., Li P.H., and Edelman E.R. Thrombosis modulates arterial drug distribution for drug-eluting stents. Circulation 111 (2005) 1619-1626
24. Falk E., Shah P.K., and Fuster V. Coronary plaque disruption. Circulation 92 (1995) 657-671
25. Finn A.V., Joner M., Nakazawa G., et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 115 (2007) 2435-2441
26. Takano M., Xie Y., Murakami D., et al. Various optical coherence tomographic findings in restenotic lesions after sirolimus-eluting stent implantation. Int J Cardiol (2008) Apr 8 [Epub ahead of print]